Medicamen Biotech Limited (MEDICAMEQ) — Working Capital to Net Assets Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Working Capital to Net Assets ratio of 49.3% as of March 2026. Working capital of Rs1.36 Billion (current assets of Rs2.24 Billion minus current liabilities of Rs879.20 Million) is measured against net assets of Rs2.76 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See MEDICAMEQ defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medicamen Biotech Limited Working Capital to Net Assets (2006–2026)
This chart shows how Medicamen Biotech Limited's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the ratio stands at 49.3%, reflecting working capital of Rs1.36 Billion against net assets of Rs2.76 Billion INR. For the complete balance sheet picture, see Medicamen Biotech Limited (MEDICAMEQ) total assets.
Annual Working Capital to Net Assets for Medicamen Biotech Limited (2006–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medicamen Biotech Limited from 2006 to 2026, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Medicamen Biotech Limited (MEDICAMEQ) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 49.3% | Rs1.36 Billion | Rs2.76 Billion | Rs2.24 Billion | Rs879.20 Million | ▲ +8.7 pp |
| 2025 | 40.6% | Rs863.84 Million | Rs2.13 Billion | Rs1.65 Billion | Rs781.65 Million | ▲ +4.3 pp |
| 2024 | 36.3% | Rs750.38 Million | Rs2.07 Billion | Rs1.60 Billion | Rs845.55 Million | ▼ -5.5 pp |
| 2023 | 41.8% | Rs807.89 Million | Rs1.93 Billion | Rs1.63 Billion | Rs825.74 Million | ▲ +7.4 pp |
| 2022 | 34.4% | Rs503.47 Million | Rs1.46 Billion | Rs1.23 Billion | Rs726.91 Million | ▲ +2.2 pp |
| 2021 | 32.2% | Rs427.59 Million | Rs1.33 Billion | Rs960.33 Million | Rs532.74 Million | ▼ -7.1 pp |
| 2020 | 39.3% | Rs476.48 Million | Rs1.21 Billion | Rs1.04 Billion | Rs564.84 Million | ▼ -15.7 pp |
| 2019 | 55.0% | Rs476.25 Million | Rs866.34 Million | Rs961.68 Million | Rs485.44 Million | ▼ -11.7 pp |
| 2018 | 66.7% | Rs497.78 Million | Rs746.08 Million | Rs909.86 Million | Rs412.08 Million | ▲ +26.7 pp |
| 2017 | 40.0% | Rs107.14 Million | Rs267.81 Million | Rs533.80 Million | Rs426.67 Million | ▲ +21.3 pp |
| 2016 | 18.7% | Rs33.52 Million | Rs179.09 Million | Rs405.95 Million | Rs372.43 Million | ▼ -3.2 pp |
| 2015 | 21.9% | Rs37.66 Million | Rs171.85 Million | Rs485.08 Million | Rs447.43 Million | ▲ +44.0 pp |
| 2014 | -22.1% | Rs-36.59 Million | Rs165.38 Million | Rs419.48 Million | Rs456.07 Million | ▲ +14.9 pp |
| 2013 | -37.0% | Rs-58.21 Million | Rs157.17 Million | Rs419.09 Million | Rs477.31 Million | ▼ -28.0 pp |
| 2012 | -9.0% | Rs-18.13 Million | Rs201.01 Million | Rs453.02 Million | Rs471.15 Million | ▼ -47.0 pp |
| 2011 | 38.0% | Rs77.62 Million | Rs204.12 Million | Rs468.25 Million | Rs390.63 Million | ▼ -16.1 pp |
| 2010 | 54.2% | Rs88.07 Million | Rs162.61 Million | Rs370.11 Million | Rs282.03 Million | ▲ +24.5 pp |
| 2009 | 29.7% | Rs38.45 Million | Rs129.60 Million | Rs274.93 Million | Rs236.47 Million | ▲ +41.9 pp |
| 2008 | -12.3% | Rs-14.19 Million | Rs115.83 Million | Rs343.47 Million | Rs357.67 Million | ▼ -13.0 pp |
| 2007 | 0.8% | Rs790.00K | Rs100.73 Million | Rs312.80 Million | Rs312.01 Million | ▼ -27.3 pp |
| 2006 | 28.1% | Rs24.04 Million | Rs85.67 Million | Rs230.54 Million | Rs206.49 Million | — |